BR112017008383A2 - método de produção melhorado - Google Patents

método de produção melhorado

Info

Publication number
BR112017008383A2
BR112017008383A2 BR112017008383A BR112017008383A BR112017008383A2 BR 112017008383 A2 BR112017008383 A2 BR 112017008383A2 BR 112017008383 A BR112017008383 A BR 112017008383A BR 112017008383 A BR112017008383 A BR 112017008383A BR 112017008383 A2 BR112017008383 A2 BR 112017008383A2
Authority
BR
Brazil
Prior art keywords
composition
recombinant protein
production method
improved production
vacuum
Prior art date
Application number
BR112017008383A
Other languages
English (en)
Inventor
Vernooij Eric
Peters Marjo
Corcoran Marta
Houchin Mary
Cao Mingyan
Choudhary Sureshkumar
Mezghebe Tesfu
Joo Kim Yoen
Original Assignee
Medimmune Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune Llc filed Critical Medimmune Llc
Publication of BR112017008383A2 publication Critical patent/BR112017008383A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D19/00—Degasification of liquids
    • B01D19/0036—Flash degasification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B3/003—Filling medical containers such as ampoules, vials, syringes or the like
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
    • B65B31/04—Evacuating, pressurising or gasifying filled containers or wrappers by means of nozzles through which air or other gas, e.g. an inert gas, is withdrawn or supplied
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Mechanical Engineering (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

este pedido é dirigido a um método de produção de frascos contendo uma composição compreendendo uma proteína recombinante. em algumas modalidades, o método compreende: (a) proporcionar um recipiente contendo uma composição compreendendo opcional-mente uma proteína recombinante em que o recipiente foi armazenado sob pressão positiva; (b) aplicar um vácuo ao recipiente contendo uma composição compreendendo uma proteína recombinante; (c) permitir que o vácuo desgaseifique a composição; e (d) encher os frascos com a composição desgaseificada compreendendo uma proteína recombinante.
BR112017008383A 2014-10-31 2015-10-30 método de produção melhorado BR112017008383A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462073459P 2014-10-31 2014-10-31
PCT/US2015/058241 WO2016069999A2 (en) 2014-10-31 2015-10-30 An improved manufacturing method

Publications (1)

Publication Number Publication Date
BR112017008383A2 true BR112017008383A2 (pt) 2018-07-31

Family

ID=55858529

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017008383A BR112017008383A2 (pt) 2014-10-31 2015-10-30 método de produção melhorado

Country Status (11)

Country Link
US (1) US10625180B2 (pt)
EP (1) EP3212510B1 (pt)
JP (1) JP6672293B2 (pt)
KR (1) KR102274472B1 (pt)
CN (1) CN107108054B (pt)
AU (1) AU2015339017B2 (pt)
BR (1) BR112017008383A2 (pt)
CA (1) CA2965678A1 (pt)
ES (1) ES2856967T3 (pt)
IL (1) IL251740B (pt)
WO (1) WO2016069999A2 (pt)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU631802B2 (en) 1988-06-14 1992-12-10 Cetus Oncology Corporation Coupling agents and sterically hindered disulfide linked conjugates prepared therefrom
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
IE63847B1 (en) 1989-05-05 1995-06-14 Res Dev Foundation A novel antibody delivery system for biological response modifiers
WO1991010741A1 (en) 1990-01-12 1991-07-25 Cell Genesys, Inc. Generation of xenogeneic antibodies
US5314995A (en) 1990-01-22 1994-05-24 Oncogen Therapeutic interleukin-2-antibody based fusion proteins
AU654811B2 (en) 1990-03-20 1994-11-24 Trustees Of Columbia University In The City Of New York, The Chimeric antibodies with receptor binding ligands in place of their constant region
AU660297B2 (en) 1990-11-09 1995-06-22 Stephen D. Gillies Cytokine immunoconjugates
US5824307A (en) 1991-12-23 1998-10-20 Medimmune, Inc. Human-murine chimeric antibodies against respiratory syncytial virus
US6818216B2 (en) 2000-11-28 2004-11-16 Medimmune, Inc. Anti-RSV antibodies
WO2002074406A1 (en) * 2001-03-14 2002-09-26 Penjet Corporation System and method for removing dissolved gas from a solution
AU2002327171A1 (en) 2001-05-01 2003-01-02 Medimmune, Inc. Crystals and structure of synagis fab
US7132100B2 (en) 2002-06-14 2006-11-07 Medimmune, Inc. Stabilized liquid anti-RSV antibody formulations
US6847898B1 (en) 2003-08-21 2005-01-25 Appleton Papers Inc. Real time determination of gas solubility and related parameters in manufacturing processes
US7786273B2 (en) 2005-03-14 2010-08-31 Medimmune, Llc Macromolecules comprising a thioether cross-link
US20070169434A1 (en) * 2006-01-26 2007-07-26 Shawn Kinney Process for aseptic vacuum filling and stoppering of low viscosity liquids in syringes
US20070175538A1 (en) 2006-01-30 2007-08-02 Jurgen Rothbauer System and method for filling containers with liquid under varying pressure conditions
BR112015009969A2 (pt) 2012-11-05 2017-07-11 Medimmune Llc método de isolamento de synagis® na ausência de benzonase

Also Published As

Publication number Publication date
KR20170077129A (ko) 2017-07-05
WO2016069999A3 (en) 2016-08-25
ES2856967T3 (es) 2021-09-28
CN107108054B (zh) 2020-10-13
US20170333812A1 (en) 2017-11-23
WO2016069999A8 (en) 2016-11-24
JP2017537890A (ja) 2017-12-21
JP6672293B2 (ja) 2020-03-25
CN107108054A (zh) 2017-08-29
EP3212510A4 (en) 2018-04-11
EP3212510A2 (en) 2017-09-06
CA2965678A1 (en) 2016-05-06
US10625180B2 (en) 2020-04-21
WO2016069999A2 (en) 2016-05-06
IL251740A0 (en) 2017-06-29
AU2015339017B2 (en) 2020-04-30
IL251740B (en) 2021-08-31
AU2015339017A1 (en) 2017-05-18
KR102274472B1 (ko) 2021-07-07
EP3212510B1 (en) 2020-12-09

Similar Documents

Publication Publication Date Title
CL2020002269A1 (es) Anticuerpo que se une a redil33; polinucleótido; vector; célula hospedadora; método para producir el anticuerpo; composición farmacéutica; producto de combinación; uso del anticuerpo para tratar una afección inflamatoria (divisional de la solicitud no. 201702433)
BR112017006736A2 (pt) anticorpos antimiostatina, polipeptídeos contendo regiões fc variantes, e métodos de utilização
BR112018011073A2 (pt) anticorpos antimiostatina, polipeptídeos contendo regiões fc variantes e métodos de utilização
BR112016010209A2 (pt) recipientes flexíveis e métodos para a produção dos mesmos
EP3844963A4 (en) IMPROVED ATTRIBUTE SUPPORT IN POINT CLOUD ENCODING
EP3387518A4 (en) Floating animated push interfaces for interactive dynamic push notifications and other content
CL2016002772A1 (es) Composiciones de insulina de rápida acción
CL2017000752A1 (es) Procedimiento para producir biomasa que tiene un alto contenido de exopolisacáridos
BR112018073628A2 (pt) anticorpos antimiostatina e métodos de utilização
BR112016023620A2 (pt) frasco, sistema que compreende tal frasco e método para produção do mesmo
BR112015030268A2 (pt) composição farmacêutica, recipiente, kit, e, método para a preparação de uma composição
CO2017005634A2 (es) Metodo para la fabricacion de una suspension que comprende un material que comprende carbonato de calcio
BR112016017010A2 (pt) Anticorpo monoclonal de fator antitecido
BR112016014880A2 (pt) Composição farmacêutica incluindo palonosetron
AR095583A1 (es) Recipiente que tiene un indicador de uso
MX2017006524A (es) Composicion adhesiva que cambia de color.
CL2016001801A1 (es) Proceso para la reconstitución de una forma sólida de una composición farmacéutica.
BR112017013532A2 (pt) composição de resina
TWD176602S (zh) 包裝用容器
BR112017007753A2 (pt) uso de uma composição cosmética que compreende ácido 10-hidroxiesteárico.
EA201691924A1 (ru) Фармацевтические композиции
AR096879A1 (es) Diutano como modificador de la reología en cementos sorel
CL2017001383A1 (es) Proceso para la fabricación de anhídrido carboxílico
EP3261138A4 (en) Piezoelectric ptzt film, and process for producing liquid composition for forming said piezoelectric film
TWD187956S (zh) 包裝容器

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]